12:00 AM
Jul 23, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Flutiform fluticasone/formoterol regulatory update

SkyePharma said the German Federal Institute for Drugs and Medical Devices (BfArM) approved flutiform fluticasone/formoterol to treat asthma. SkyePharma said partner Mundipharma plans to launch the product this year in Germany, which will trigger a...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >